article thumbnail

A new dawn of the genomic age: five areas set to be transformed in 2023

pharmaphorum

Genomic insights will increasingly be used to reduce the hundreds of millions of pounds wasted administering drugs that are ineffective due to an individual’s genetic makeup. Fulfilling the promise of genomics depends on having the most accurate and complete picture of genetic variation as possible.

Genome 129
article thumbnail

Can genetic data be a magic bullet for drug R&D?

pharmaphorum

The same is becoming true for the healthcare industry, and one of the first major breakthroughs in the area was the 100,000 Genomes Project. The information gathered from the project is still providing insights today, a decade later. Scientists are able to study the aggregated, de-identified genetics of these individuals.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Why genomic healthcare data matters in the development of new therapies 

Drug Discovery World

One might argue that this all started getting exciting with the launch of the Human Genome Project, which the National Human Genome Research Institute consider to be one of the greatest scientific feats in history 1. DDW’s Megan Thomas observes developments of accessibility in this sector and the potential impact. .

Genome 98
article thumbnail

Q&A: Gene therapy opportunities from long-read sequencing 

Drug Discovery World

We’re delighted to be working with Genomics England to demonstrate how PacBio HiFi sequencing can help identify the genetic causes of rare disease that remain undiagnosed after short read sequencing. In antimicrobial resistance research, scientists need continual genomic-level analysis to understand resistance and the evolution of microbes.